Anti-inflammatory profile of FTO gene expression in adipose tissues from morbidly obese women

Cellular Physiology and Biochemistry

Volumn 26, Issue 6, 2010, Pages 1041-1050

  Terra, Ximena ^a,b   Auguet, Teresa ^a,b,d   Porras, Jose Antonio ^b,d   Quintero, Yunuen ^a   Aguilar, Carmen ^a   Luna, Anna Maria ^a   Hernández, Mercé ^c,d   Sabench, Fátima ^c,d   Del Castillo, Daniel ^c,d   Richart, Cristóbal ^a,b,d  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^d INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

Author keywords

Adipokines; Adipose tissue FTO; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPONECTIN RECEPTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRIC PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; CORRELATIONAL STUDY; ELECTIVE SURGERY; FAT MASS AND OBESITY ASSOCIATED GENE; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MORBID OBESITY; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BYPASS; SUBCUTANEOUS FAT; TISSUE SECTION;

EID: 78651253434     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323979     Document Type: Article

References (38)

1. Koh KK, Han SH, Quon MJ: Inflammatory Markers and the Metabolic Syndrome: Insights From Therapeutic Interventions. J Am Coll Cardiol 2005;46:1978-1985.
2. Kontogianni MD, Zampelas A, Tsigos C: Nutrition and Inflammatory Load. Ann NY Acad Sci 2006;1083:214-238.
3. Malavazos AE, Corsi MM, Ermetici F, Coman C, Sardanelli F, Rossi A, Morricone L, Ambrosi B: Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: Relationship with abdominal fat deposition. Nutr Metab Cardiovas 2007;17:294-302.
4. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C: The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 2005;183:308-315.
5. Jonsson A, Renström F, Lyssenko V, Brito EC, Isomaa B, Berglund G, Nilsson PM, Groop L, Franks PW: Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia 2009;52:1334-1338.
6. Müller TD, Hinney A, Scherag A, Nguyen TT, Schreiner F, Schäfer H, Hebebrand J, Roth CL, Reinehr T: 'Fat Mass and Obesity Associated' Gene (FTO): No Significant Association of Variant rs9939609 with Weight Loss in a Lifestyle Intervention and Lipid Metabolism Markers in German Obese Children and Adolescents. BMC Med Genet 2008;9:85.
7. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI: A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity. Science 2007;316:889-894.
8. Tews D, Fischer-Posovszky P, Wabitsch M: FTO - Friend or Foe? Horm Metab Res 2009;42:75-80.
9. Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LMS, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercberg S, Le Stunff C, Bougneres P, Kovacs P, Marre M, Balkau B, Cauchi S, Chevre J, Froguel P: Variation in FTO Contributes to Childhood Obesity and Severe Adult Obesity. Nat Genet 2007;39:724-726.
10. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G, Dei M, Lai S, Maschio A, Busonero F, Mulas A, Ehret GB, Fink AA, Weder AB, Cooper RS, Galan P, Chakravarti A, Schlessinger D, Cao A, Lakatta E, Abecasis GR: Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007;3:e115.
11. Stratakis CA, Lafferty A, Taymans SE, Gafni RI, Meck JM, Blancato J: Anisomastia Associated with Interstitial Duplication of Chromosome 16, Mental Retardation, Obesity, Dysmorphic Facies, and Digital Anomalies: Molecular Mapping of a New Syndrome by Fluorescent in Situ Hybridization and Microsatellites to 16q13 (D16S419-D16S503). J Clin Endocrinol Metab 2000;85:3396-3401.
12. Tschritter O, Preissl H, Yokoyama Y, Machicao F, Haering H, Fritsche A: Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia 2007;50:2602-2603.
13. Gerken T, Girard CA, Tung YL, Webby CJ, Saudek V, Hewitson KS, Yeo GSH, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O'Rahilly S, Schofield CJ: The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase. Science 2007;318:1469-1472.
14. Sanchez-Pulido L, Andrade-Navarro M: The FTO (fat mass and obesity associated) gene codes for a novel member of the non-heme dioxygenase superfamily. BMC Biochemistry 2007;8:23.
15. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW: Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans. Endocrinology 2004;145:2273-2282.
16. Hajer GR, Van Haeften TW, Visseren FLJ: Adipose Tissue Dysfunction in Obesity, Diabetes, and Vascular Diseases. Eur Heart J 2008;29:2959-2971.
17. Klöting N, Schleinitz D, Ruschke K, Berndt J, Fasshauer M, Tönjes A, Schön M, Kovacs P, Stumvoll M, Blüher M: Inverse Relationship Between Obesity and FTO Gene Expression in Visceral Adipose Tissue in Humans. Diabetologia 2008;51:641-647.
18. Wåhlén K, Sjölin E, Hoffstedt J: The Common rs9939609 Gene Variant of the Fat Mass- and Obesity-Associated Gene FTO is Related to Fat Cell Lipolysis. J Lipid Res 2008;49:607-611.
19. Zabena C, González-Sánchez J, Martínez-Larrad MT, Torres-García A, Alvarez-Fernández-Represa J, Corbatón- Anchuelo A, Pérez-Barba M, Serrano-Ríos M: The FTO Obesity Gene. Genotyping and Gene Expression Analysis in Morbidly Obese Patients. Obes Surg 2009;19:87-95.
20. Stratigopoulos G, Padilla SL, LeDuc CA, Watson E, Hattersley AT, McCarthy MI, Zeltser LM, Chung WK, Leibel RL: Regulation of FTO/FTM Gene Expression in Mice and Humans. Am J Physiol Regul Integr Comp Physiol 2008;294:1185-1196.
21. Qi L, Kang K, Zhang C, Van Dam RM, Kraft P, Hunter D, Lee CH, Hu FB: Fat Mass-and Obesity-Associated (FTO) Gene Variant Is Associated With Obesity. Diabetes 2008;57:3145-3151.
22. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning J, Rüther U: Inactivation of the FTO Gene Protects from Obesity. Nature 2009;458:894-898.
23. Frayling TM: Genome-Wide Association Studies Provide New Insights into Type 2 Diabetes Aetiology. Nat Rev Genet 2007;8:657-662.
24. Ahima RS: Metabolic Actions of Adipocyte Hormones: Focus on Adiponectin. Obesity 2006;14:9-15.
25. Neels JG, Olefsky JM: Inflamed fat: what starts the fire? J Clin Invest 2006;116:33-35.
26. Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, Brixen K, Andersen M: Subcutaneous Rather than Visceral Adipose Tissue Is Associated with Adiponectin Levels and Insulin Resistance in Young Men. J Clin Endocrinol Metab 2009;94:4010-4015.
27. Palou M, Priego T, Sánchez J, Rodríguez AM, Palou A, Picó C: Gene expression patterns in visceral and subcutaneous adipose depots in rats are linked to their morphologic features. Cell Physiol Biochem 2009;24:547-556.
28. Samaras K, Botelho NK, Chisholm DJ, Lord RV: Subcutaneous and Visceral Adipose Tissue FTO Gene Expression and Adiposity, Insulin Action, Glucose Metabolism, and Inflammatory Adipokines in Type 2 Diabetes Mellitus and in Health. Obes Surg 2009;20:108-113.
29. Church C, Lee S, Bagg EA, McTaggart JS, Deacon R, Gerken T, Lee A, Moir L, Mecinoviæ J, Quwailid MM, Schofield CJ, Ashcroft FM, Cox RD: A Mouse Model for the Metabolic Effects of the Human Fat Mass and Obesity Associated FTO Gene. PLoS Genet 2009;5(8):e1000599.
30. Samaras K, Botelho NK, Chisholm DJ, Lord RV: Subcutaneous and Visceral Adipose Tissue Gene Expression of Serum Adipokines That Predict Type 2 Diabetes. Obesity 2010;18:884-889.
31. Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR, Stumvoll M, Blüher M: Vaspin Gene Expression in Human Adipose Tissue: Association with Obesity and Type 2 Diabetes. Biochem Biophys Res Commun 2006;339:430-436.
32. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R: Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation. Circulation 2005;111:1448-1454.
33. Fain JN: Release of Interleukins and Other Inflammatory Cytokines by Human Adipose Tissue Is Enhanced in Obesity and Primarily due to the Nonfat Cells. Vitam Horm 2006;74:443-477.
34. Vaughan T, Li L: Molecular mechanism underlying the inflammatory complication of leptin in macrophages. Mol Immunol 2010;47(15):2515-2518.
35. Bortolotto J, Margis R, Ferreira A, Padoin A, Mottin C, Guaragna R: Adipose Tissue Distribution and Quantification of PPARbeta/delta and PPARgamma1-3 mRNAs: Discordant Gene Expression in Subcutaneous, Retroperitoneal and Visceral Adipose Tissue of Morbidly Obese Patients. Obes Surg 2007;17:934-940.
36. Stienstra R, Mandard S, Patsouris D, Maass C, Kersten S, Muller M: Peroxisome Proliferator-Activated Receptor Alpha Protects against Obesity-Induced Hepatic Inflammation. Endocrinology 2007;148:2753-2763.
37. Vimaleswaran KS, Li S, Zhao JH, Luan J, Bingham SA, Khaw K, Ekelund U, Wareham NJ, Loos RJ: Physical activity attenuates the body mass index-increasing influence of genetic variation in the FTO gene. Am J Clin Nutr 2009;90:425-428.
38. Mitchell JA, Church TS, Rankinen T, Earnest CP, Sui X, Blair SN: FTO Genotype and the Weight Loss Benefits of Moderate Intensity Exercise. Obesity (Silver Spring) 2009;18:641-643.